TY - JOUR
T1 - Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor
AU - Sasazuki, Takehiko
AU - Juji, Takeo
AU - Morishima, Yasuo
AU - Kinukawa, Naoko
AU - Kashiwabara, Hidehiko
AU - Inoko, Hidetoshi
AU - Yoshida, Takato
AU - Kimura, Akinori
AU - Akaza, Tatsuya
AU - Kamikawaji, Nobuhiro
AU - Kodera, Yoshihisa
AU - Takaku, Fumimaro
AU - Nose, Yoshiaki
AU - Ono, Takashi
AU - Sakamaki, Takeo
AU - Kato, Shunichi
AU - Akiyama, Yuichi
AU - Okamoto, Shinichiro
AU - Dohy, Hiroo
AU - Harada, Mine
AU - Asano, Shigetaka
PY - 1998/10/22
Y1 - 1998/10/22
N2 - Background. The requirements with respect to HLA compatibility and the relative importance of matching for individual class I and class II HLA alleles in the transplantation of hematopoietic stem cells from unrelated donors have not yet been established. Methods. We performed retrospective DNA typing of alleles at 11 polymorphic loci of HLA genes in 440 recipients of hematopoietic stem cells from unrelated donors who were serologically identical with their respective recipients for HLA-A, B, and DR antigens. Of these recipients, 80 percent had leukemia; the rest had lymphoma, marrow failure, or a congenital disorder. Results. Multivariate analysis showed that incompatibility for HLA-A alleles and incompatibility for HLA-C alleles were independent risk factors for severe acute graft-versus-host disease (GVHD) (HLA-A, P=0.006; HLA-C, P=0.001). Mismatching of HLA-A, but not of HLA-C, alleles was an independent risk factor for death (P<0.001). Mismatching of HLA-C alleles was a significant risk factor for relapse of leukemia (P=0.035). HLA-B disparity was a significant risk factor for both GVHD and death in the univariate analysis, but not in the multivariate analysis. Disparities in class II HLA alleles of the DRB1, DQA1, DQB1, DPA1, and DPB1 loci were not identified as significant risk factors for acute GVHD or death in the multivariate analysis. Conclusions. Genomic typing of class I HLA alleles adds substantially to the success of transplantation of hematopoietic stem cells from unrelated donors, even if the donors are serologically identical to their recipients with respect to HLA-A, B, and DR antigens.
AB - Background. The requirements with respect to HLA compatibility and the relative importance of matching for individual class I and class II HLA alleles in the transplantation of hematopoietic stem cells from unrelated donors have not yet been established. Methods. We performed retrospective DNA typing of alleles at 11 polymorphic loci of HLA genes in 440 recipients of hematopoietic stem cells from unrelated donors who were serologically identical with their respective recipients for HLA-A, B, and DR antigens. Of these recipients, 80 percent had leukemia; the rest had lymphoma, marrow failure, or a congenital disorder. Results. Multivariate analysis showed that incompatibility for HLA-A alleles and incompatibility for HLA-C alleles were independent risk factors for severe acute graft-versus-host disease (GVHD) (HLA-A, P=0.006; HLA-C, P=0.001). Mismatching of HLA-A, but not of HLA-C, alleles was an independent risk factor for death (P<0.001). Mismatching of HLA-C alleles was a significant risk factor for relapse of leukemia (P=0.035). HLA-B disparity was a significant risk factor for both GVHD and death in the univariate analysis, but not in the multivariate analysis. Disparities in class II HLA alleles of the DRB1, DQA1, DQB1, DPA1, and DPB1 loci were not identified as significant risk factors for acute GVHD or death in the multivariate analysis. Conclusions. Genomic typing of class I HLA alleles adds substantially to the success of transplantation of hematopoietic stem cells from unrelated donors, even if the donors are serologically identical to their recipients with respect to HLA-A, B, and DR antigens.
UR - http://www.scopus.com/inward/record.url?scp=0032558686&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032558686&partnerID=8YFLogxK
U2 - 10.1056/NEJM199810223391701
DO - 10.1056/NEJM199810223391701
M3 - Article
C2 - 9780337
AN - SCOPUS:0032558686
SN - 0028-4793
VL - 339
SP - 1177
EP - 1185
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 17
ER -